Johanna Shulman

Johanna Shulman is an accomplished professional in the pharmaceutical industry, currently serving as Vice President and Program Lead for Myelofibrosis at Karyopharm Therapeutics Inc. since August 2022. Prior to this role, Johanna held various significant positions at Amgen from February 2017 to August 2022, including Executive Director of Global Commercialization Strategy for the Solid Tumor Pipeline and Executive Director of US Leukemia Sales & Marketing. Johanna's earlier experience at Novartis Oncology, spanning from February 2003 to January 2017, included roles such as Area Sales Manager, Senior Global Brand Director, and Director of New Product Strategy. Johanna Shulman holds a B.Sc (Hons) in Biology from Queen's University and an M.Sc in Molecular Genetics from the University of Toronto.